Prognostic Role of Rb, p16, Cyclin D1 Proteins in Soft Tissue Sarcomas
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The aim of this study was to determine the expressions of Rb, p16, and cyclin D1 in soft tissue sarcomas, and we also wanted to identify the prognostic factors according to the clinicalpathologic features. Materials and Methods We reviewed the charts and radiographic films of 66 sarcoma patients. Tissue samples were collected from these patients. Immunochemistry was performed using formalin-fixed, paraffinembedded tissue samples to examine the expressions of p16, Rb, and cyclin D1 proteins. Results The median duration of overall survival was 47.8 months (range, 20.0 to 70.7 months) and the 5 years survival rate was 39%. As for the correlation between the degree of immunohistochemical staining for Rb protein and the histological tumor grades, there was a significant difference with a p-value of 0.019. However, no significant correlation was shown for p16 and cyclin D1. The overall survival duration of the Rb negative group (staining cell ＜20%)and the heterogeneous group (cell staining 20 to 80%) was 53.5±6.6 months and the overall survival duration of the Rb homogeneous group was 18.3±6.4 months, and there was a significant difference with a p-value of 0.016. However, no significant difference was shown between the survival rate according to the p16 and cyclin D1 expressions. On the multivariate analysis that was done with Rb, p16, the tumor size, grade and site, and patient age, the Rb gene expression was the most significant independent prognostic factor with a risk ratio of 3.01 (p=0.04). Conclusion The expression of Rb protein was correlated with the histologic grade and overall survival of patients with soft tissue sarcomas.
Abstract
Purpose The aim of this study was to determine the expressions of Rb, p16, and cyclin D1 in soft tissue sarcomas, and we also wanted to identify the prognostic factors according to the clinicalpathologic features. Materials and Methods We reviewed the charts and radiographic films of 66 sarcoma patients. Tissue samples were collected from these patients. Immunochemistry was performed using formalin-fixed, paraffinembedded tissue samples to examine the expressions of p16, Rb, and cyclin D1 proteins. Results The median duration of overall survival was 47.8 months (range, 20.0 to 70.7 months) and the 5 years survival rate was 39%. As for the correlation between the degree of immunohistochemical staining for Rb protein and the histological tumor grades, there was a significant difference with a p-value of 0.019. However, no significant correlation was shown for p16 and cyclin D1. The overall survival duration of the Rb negative group (staining cell ＜20%)and the heterogeneous group (cell staining 20 to 80%) was 53.5±6.6 months and the overall survival duration of the Rb homogeneous group was 18.3±6.4 months, and there was a significant difference with a p-value of 0.016. However, no significant difference was shown between the survival rate according to the p16 and cyclin D1 expressions. On the multivariate analysis that was done with Rb, p16, the tumor size, grade and site, and patient age, the Rb gene expression was the most significant independent prognostic factor with a risk ratio of 3.01 (p=0.04). Conclusion The expression of Rb protein was correlated with the histologic grade and overall survival of patients with soft tissue sarcomas.
참고문헌 (17)
- Enzinger FM, "Soft tissue tumors. 3rd ed" (1995), Mosby
- Li XQ, "Assessing prognosis for high-grade softtissue sarcomas: search for a marker", Ann Surg Oncol, 3, pp.550~557 (1996)
- Yao J, "Infrequent mutation of the p16", MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma, 1998, pp.4, 1065~1070
- Karpeh MS, "Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas", Br J Cancer, 72, pp.986~991 (1995)
- Kim SH, "Overexpression of cyclin D1 is associated with poor prognosis in extremity soft-tissue sarcomas", Clin Cancer Res, 4, pp.2377~2382 (1998)
- Meye A, "No p16INK4A", CDKN2, J Pathol, pp.1998, 184[DOI]
- Coindre JM, "Reproducibility of a histopathologic grading system for adult soft tissue sarcoma", Cancer, 58, pp.306~309 (1986)
- Brambilla E, "Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance", J Pathol, 188, pp.351~360 (1999)
- Huang CI, "p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung", Br J Cancer, 82, pp.374~380 (2000)
- Kawabuchi B, "p16 inactivation in small-sized lung adenocarcinoma: its association with poor prognosis", Int J Cancer, 84, pp.49~53 (1999)
- Hommura F, "Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers", Br J Cancer, 81, pp.696~701 (1999)
- Kusume T, "The p16-cyclin D1", CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer, 1999, pp.5, 4152~5157
- Salvesen HB, "Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis", Clin Cancer Res, 6, pp.153~159 (2000)
- Takeuchi H, "Altered p16", MTS1, PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus, pp.Clin Cancer Res, 1997[DOI]
- Cohen JA, "Loss of RB and MTS1", CDKN2 (p16) expression in human sarcomas, 1997, pp.28, 893~898
- Kim SH, "Prognostic role of cyclin D1 in retroperitoneal sarcomas", Cancer, 91, pp.428~434 (2001)
- Wurl P, "Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas", Cancer Lett, 139, pp.159~165 (1999)